October 15, 2021

Medical Trend

Medical News and Medical Resources

Australia accepted China SINOVAC vaccine vaccinated by foreigners

Australia accepted China SINOVAC vaccine vaccinated by foreigners

Australia accepted China SINOVAC vaccine vaccinated by foreigners



Australia accepted China SINOVAC vaccine vaccinated by foreigners.

Following the US step, Australia announced the approval of China SINOVAC vaccine vaccinated by foreigners.

The Australian Medicines Agency (TGA) announced the recognition of SINOVAC Vaccine in China and Covishield Covid-19 Vaccine in India, paving the way for people who have been vaccinated to enter Australia.

Australia accepted China SINOVAC vaccine vaccinated by foreigners

A press release issued on the website of the Australian Prime Minister’s Office on October 1 pointed out that the TGA announced on the same day a preliminary assessment of the protection data provided by the Coronavac vaccine of SINOVAC and the Covishield vaccine of India (produced by AstraZeneca in cooperation with the Serum Institute of India), and recommended These two vaccines are listed as “recognised vaccines (recognised vaccines)”.

The press release stated that the declaration of a COVID-19 vaccine as a “recognized vaccine” is separate from the regulatory decision on whether to approve it for vaccination in Australia.

TGA has not approved the above two vaccines in Australia.Currently, TGA approved vaccines for use in Australia, including Pfizer/BioNTech vaccine (Comirnaty), AstraZeneca vaccine (Vaxzevria), Moderna vaccine (Spikevax) and Johnson & Johnson’s Janssen vaccine.

However, the notice also stated that the recognition of these two vaccines is “milestone”, which enables more Australian citizens who have received these vaccines outside Australia to return home as soon as possible.According to the Australian Broadcasting Corporation, TGA pointed out in its latest statement that the agency has evaluated 6 vaccines this time.

They are widely used in Asia-Pacific countries such as China and India.

Many of the international immigrants that Australia usually receives come from These countries. Due to insufficient data, TGA did not recognize the other four vaccines in the preliminary assessment, namely BIBP-CorV developed by China National Pharmaceutical Group, Convidecia produced by China’s Kangsino Biotech Co., Ltd., and Bharat Biotech, India.

Covaxin manufactured by Bharat Biotech and Sputnik V developed by the Gamaleya Institute in Russia. TGA said that with more data, these vaccines may be recognized in the next few weeks or months.

According to Bloomberg News, Australia plans to open its international borders in November 2021. At present, the country’s first vaccination rate is close to 80%, and 55% of the population has been vaccinated with two doses.

Scott Morrison said on October 1 that all Australian citizens and permanent residents who have received two doses of the COVID-19 vaccine will be allowed to take a 7-day home quarantine after returning to Australia, while those who have not received the COVID-19 vaccine will still have to In designated facilities approved by the government, a 14-day hotel quarantine is adopted.

It is worth mentioning that in September, Chinese vaccines such as SINOVAC and Sinopharm won the “default” of the United States.

On September 20, the United States announced that all people who received the vaccine certified by the World Health Organization for emergency use would be considered “fully vaccinated” and could enter the United States.

This means that foreign travelers who have been vaccinated with Chinese vaccines that have been included in the WHO’s emergency use list, such as SINOVAC and Sinopharm, can present a “full vaccination” certificate and a nucleic acid negative report within 3 days before boarding. Entry into the United States.

Other news about SINOVAC vaccines:

Malaysia Announced Formal Conditional Approval of China’s SINOVAC COVID-19 Vaccine for Adolescents Over 12 Years Old

Malaysian Health Director Nur Hisham announced on October 1, local time that the Malaysian Drug Regulatory Authority has made a decision to formally and conditionally approve the Chinese SINOVAC COVID-19 Vaccine for adolescents over 12 years of age.

He said that SINOVAC vaccine is the second COVID-19 vaccine approved by the Malaysian government for vaccination of young people.

Nur Hisham said that the Malaysian Drug Regulatory Authority recommends giving priority to young people aged 12 to 17 who do not have underlying diseases and are not suitable for Pfizer vaccination to be vaccinated against the COVID-19 vaccine.

Nur Hisham stated that Malaysia has evaluated the quality, safety and effectiveness of the vaccine based on the latest research data, and the SINOVAC vaccine has been approved. 

Australia accepted China SINOVAC vaccine vaccinated by foreigners

(source:internet, reference only)


Disclaimer of medicaltrend.org